Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy
Ying Shen, Jie Liu, Baiyan Wang, Yilin Zhang, Yan Xu, Xiaman Wang, Yachun Jia, Xin Meng, Xugeng Wang, Xiao-Hu Fan, Aili He, Wanhong Zhao
Topics & Concepts
Chimeric antigen receptorMedicineMultiple myelomaAntigenImmunotherapyInternal medicineGastroenterologyRefractory (planetary science)ImmunologyCancerBiologyAstrobiologyCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsLymphoma Diagnosis and Treatment